Replication stress triggers microsatellite destabilization and hypermutation leading to clonal expansion in vitro.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 10 07 2018
accepted: 31 07 2019
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 31 12 2019
Statut: epublish

Résumé

Mismatch repair (MMR)-deficient cancers are characterized by microsatellite instability (MSI) and hypermutation. However, it remains unclear how MSI and hypermutation arise and contribute to cancer development. Here, we show that MSI and hypermutation are triggered by replication stress in an MMR-deficient background, enabling clonal expansion of cells harboring ARF/p53-module mutations and cells that are resistant to the anti-cancer drug camptothecin. While replication stress-associated DNA double-strand breaks (DSBs) caused chromosomal instability (CIN) in an MMR-proficient background, they induced MSI with concomitant suppression of CIN via a PARP-mediated repair pathway in an MMR-deficient background. This was associated with the induction of mutations, including cancer-driver mutations in the ARF/p53 module, via chromosomal deletions and base substitutions. Immortalization of MMR-deficient mouse embryonic fibroblasts (MEFs) in association with ARF/p53-module mutations was ~60-fold more efficient than that of wild-type MEFs. Thus, replication stress-triggered MSI and hypermutation efficiently lead to clonal expansion of cells with abrogated defense systems.

Identifiants

pubmed: 31477700
doi: 10.1038/s41467-019-11760-2
pii: 10.1038/s41467-019-11760-2
pmc: PMC6718401
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3925

Références

Nature. 2007 Jul 19;448(7151):375-9
pubmed: 17637672
Mutat Res. 2000 Apr;462(2-3):311-22
pubmed: 10767641
Nature. 2005 Apr 14;434(7035):864-70
pubmed: 15829956
Nat Genet. 1997 Dec;17(4):423-30
pubmed: 9398843
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nature. 1998 Dec 17;396(6712):643-9
pubmed: 9872311
Mol Cell. 2006 May 19;22(4):501-10
pubmed: 16713580
Nature. 2005 Apr 14;434(7035):907-13
pubmed: 15829965
PLoS Comput Biol. 2017 Jul 18;13(7):e1005609
pubmed: 28719607
J Biol Chem. 2006 Oct 13;281(41):30305-9
pubmed: 16905530
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2538-43
pubmed: 11226274
DNA Repair (Amst). 2002 Nov 3;1(11):881-93
pubmed: 12531017
Science. 2015 Jan 2;347(6217):78-81
pubmed: 25554788
Trends Genet. 1993 Apr;9(4):138-41
pubmed: 8516849
J Cell Biol. 1963 May;17:299-313
pubmed: 13985244
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):776-81
pubmed: 12552134
Annu Rev Cancer Biol. 2017 Mar;1:119-140
pubmed: 29399660
Annu Rev Microbiol. 2003;57:579-608
pubmed: 14527292
DNA Repair (Amst). 2013 Sep;12(9):691-8
pubmed: 23731732
Cancer Res. 2008 Nov 1;68(21):8657-60
pubmed: 18974105
Annu Rev Genet. 2015;49:291-313
pubmed: 26436461
Elife. 2014 Aug 01;3:e02725
pubmed: 25085081
Genes Dev. 2013 Jul 15;27(14):1610-23
pubmed: 23873943
Nature. 1997 Apr 10;386(6625):623-7
pubmed: 9121588
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Cell. 2013 Nov 21;155(5):1088-103
pubmed: 24267891
Nat Genet. 2000 Nov;26(3):375-8
pubmed: 11062484
J Biol Chem. 2013 May 10;288(19):13269-77
pubmed: 23536184
Cancer Cell. 2004 Aug;6(2):139-50
pubmed: 15324697
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
PLoS Biol. 2017 Jun 8;15(6):e2001477
pubmed: 28594817
Cell. 2011 Nov 23;147(5):1040-53
pubmed: 22118461
Mol Cell Biol. 2006 Oct;26(20):7696-706
pubmed: 17015482
Curr Opin Genet Dev. 2008 Jun;18(3):273-9
pubmed: 18662779
Nat Rev Cancer. 2017 Jul 25;17(8):489-501
pubmed: 28740117
Nature. 2015 Feb 12;518(7538):258-62
pubmed: 25642963
Science. 2017 Oct 13;358(6360):234-238
pubmed: 28912133
Cell Death Dis. 2015 Mar 19;6:e1697
pubmed: 25789972
Nature. 2011 Sep 11;478(7367):64-9
pubmed: 21909114
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
Mol Cell. 1999 Oct;4(4):511-8
pubmed: 10549283
Science. 2017 Mar 24;355(6331):1330-1334
pubmed: 28336671
Cancer Biomark. 2006;2(1-2):69-86
pubmed: 17192061
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4247-52
pubmed: 18337503
PLoS One. 2011;6(8):e23432
pubmed: 21858116
Genes Dev. 2000 Apr 15;14(8):927-39
pubmed: 10783165
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
BMC Bioinformatics. 2008 Dec 10;9:530
pubmed: 19077204
Nucleic Acids Res. 2015 Nov 16;43(20):9835-55
pubmed: 26354865
Nat Rev Mol Cell Biol. 2006 May;7(5):335-46
pubmed: 16612326
Nature. 2015 Feb 12;518(7538):254-7
pubmed: 25642960
Nature. 2006 Nov 30;444(7119):633-7
pubmed: 17136093
Nature. 2004 Nov 18;432(7015):338-41
pubmed: 15549096
Biochem Biophys Res Commun. 2013 Mar 1;432(1):34-9
pubmed: 23376716
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Lung Cancer. 2005 Jul;49 Suppl 1:S95-8
pubmed: 15950811
Hum Mutat. 2004 Mar;23(3):219-21
pubmed: 14974079
Nucleic Acids Res. 1998 Mar 1;26(5):1173-8
pubmed: 9469823
J Cell Biol. 2015 Mar 2;208(5):563-79
pubmed: 25733714
Cell. 2013 Mar 14;152(6):1226-36
pubmed: 23498933
Mutat Res. 2010 Feb;696(2):160-6
pubmed: 20100592
PLoS One. 2010 Jan 21;5(1):e8821
pubmed: 20098673
Nat Cell Biol. 2004 Feb;6(2):168-70
pubmed: 14755273
Cell Rep. 2015 Dec 29;13(12):2728-40
pubmed: 26711340
Cancer Res. 2004 Jul 15;64(14):4817-25
pubmed: 15256451
Genes Cells. 2016 Jul;21(7):789-97
pubmed: 27251002
Science. 2011 Dec 23;334(6063):1713-6
pubmed: 22194578

Auteurs

Yusuke Matsuno (Y)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science, Kagurazaka, Shinjuku-ku, Tokyo, 162-8601, Japan.

Yuko Atsumi (Y)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Atsuhiro Shimizu (A)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Kotoe Katayama (K)

Human Genome Center, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.

Haruka Fujimori (H)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Biological Science and Technology, Tokyo University of Science, Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan.

Mai Hyodo (M)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Biological Science and Technology, Tokyo University of Science, Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan.

Yusuke Minakawa (Y)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Biological Science and Technology, Tokyo University of Science, Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan.

Yoshimichi Nakatsu (Y)

Department of Medical Biophysics and Radiation Biology, Faculty of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Syuzo Kaneko (S)

Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Ryuji Hamamoto (R)

Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Chuo-ku, Tokyo, 103-0027, Japan.

Teppei Shimamura (T)

Division of Systems Biology, Graduate School of Medicine, Nagoya University, Tsurumai-cho, Syouwa-ku, Nagoya, 466-8550, Japan.

Satoru Miyano (S)

Human Genome Center, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.

Teruhisa Tsuzuki (T)

Department of Medical Biophysics and Radiation Biology, Faculty of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Fumio Hanaoka (F)

Faculty of Science, Gakushuin University, Mejiro, Toshima-ku, Tokyo, 171-8588, Japan.
National Institute of Genetics, Mishima, Shizuoka, 411-8540, Japan.

Ken-Ichi Yoshioka (KI)

Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kyoshiok@ncc.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH